University of Minnesota. Driven to Discover.
The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.
Two case contacts have fevers, and 2 nurses who cared for the man also have symptoms.
The WHO is stepping up its response in Europe, as cases surge in Tunisa and researchers plot at-risk US sites.
The Drug Resistance Index shows disparities in the effectiveness of antibiotics in high- and low-income countries.
Barriers in many countries limit treatment options and prevent people from getting the antibiotics they need.
Though success has been shown in only 2 patients, recruitment of more patients is under way.
The findings are the first reported of the hypervirulent, highly resistant strain outside of China.
India's government may be nearing a ban on using the antibiotic of last resort for growth promotion.
In 17 nations, most notably China and India, broader-spectrum drugs are more widely used.
Alongside the finding that progress has stalled in hard-hit countries, the WHO and partners launch a new response strategy.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.